Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010

Canadian Journal of Gastroenterology

Volumn 24, Issue 12, 2010, Pages 705-714

  Leddin, Desmond J ^a   Enns, Robert ^b   Hilsden, Robert ^c   Plourde, Victor ^d,e   Rabeneck, Linda ^f   Sadowski, Daniel C ^g   Singh, Harminder ^h  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d Centre de Santé et de Services Sociaux Pierre Boucher   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

^h UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Colorectal neoplasia; Disease prevention; Screening

Indexed keywords

BARIUM; DNA;

AFRICAN AMERICAN; AGE DISTRIBUTION; BARIUM ENEMA; CANADA; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; DNA DETERMINATION; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; GASTROINTESTINAL ENDOSCOPY; GENETIC SCREENING; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; IMMUNOCHEMISTRY; MEDICAL SOCIETY; OCCULT BLOOD TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SIGMOIDOSCOPY; UNITED STATES; UPPER GASTROINTESTINAL BLEEDING; UPPER GASTROINTESTINAL TRACT; ARTICLE; COLORECTAL TUMOR; CONSENSUS; EARLY DIAGNOSIS; GASTROENTEROLOGY; MASS SCREENING; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; RISK FACTOR;

CANADA; COLORECTAL NEOPLASMS; CONSENSUS; EARLY DETECTION OF CANCER; GASTROENTEROLOGY; HUMANS; MASS SCREENING; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SOCIETIES, MEDICAL;

EID: 79953015202     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/683171     Document Type: Review

References (72)

1. Canadian Cancer Society and NCIO Canada, Canadian cancer statistics 2008. 2008, Canadian Cancer Society: Toronto. 〈http://www.cancer.ca/~/media/CCS/ Canada%20wide/Files%20List/ English%20files%20heading/ pdf%20not%20in%20publications%20 section/ Canadian%20Cancer%20Society%20Statistics%20PDF%20 2008-614137951.ashx〉 (Accessed on October 28, 2010).
2. Leddin D, Hunt R, Champion M, et al. Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. Can J Gastroenterol 2004;18:93-9. (Pubitemid 38418034)
3. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627-37.
4. Dominic OG, McGarrity T, Dignan M, Lengerich EJ. American College of Gastroenterology Guidelines for colorectal cancer screening 2008. Am J Gastroenterol 2009;104:2626-7;
5. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95. (Pubitemid 351615355)
6. International Agency for Research on Cancer and World Health Organization. Cervix cancer screening, 1st edn, vol 10. Lyon: IARC Press, 2005.
7. Madlensky L, Goel V, Polzer J, Ashbury FD. Assessing the evidence for organised cancer screening programmes. Eur J Cancer 2003;39:1648-53. (Pubitemid 36897600)
8. Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 1994;29:468-73. (Pubitemid 24144518)
9. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71. (Pubitemid 26400241)
10. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71. (Pubitemid 23131388)
11. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): An update. Am J Gastroenterol 2008;103:1541-9. (Pubitemid 351813919)
12. Heitman S, Au F, Hilsden R, Manns B. Fecal immunochemical testing in colorectal cancer screening of average risk individuals: Economic evaluation. Health OCAfDaTi, 2009. 〈http://www.acmts. ca/media/pdf/M0012-FIT-Economic- Evaluation-L3-e.pdf〉 (Accessed on October 8, 2010).
13. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: A decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:659-69.
14. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: An update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:727-37, W237-42.
15. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: A targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:638-58.
16. Cheng TI, Wong JM, Hong CF, et al. Colorectal cancer screening in asymptomaic adults: Comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests. J Formos Med Assoc 2002;101:685-90.
17. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007;146:244-55. (Pubitemid 351650610)
18. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422-8. (Pubitemid 41096630)
19. Nakama H, Zhang B, Zhang X. Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer. Eur J Cancer 2001;37:398-401. (Pubitemid 32182330)
20. Hol L, Wilschut JA, van Ballegooijen M, et al. Screening for colorectal cancer: Random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009;100:1103-10.
21. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90. (Pubitemid 351899018)
22. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003;10:117-22. (Pubitemid 38296846)
23. Rabeneck L, Zwaal C, Goodman JH, Mai V, Zamkanei M. Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: Evidentiary base and recommendations. Clin Biochem 2008;41:1289-305.
24. Coombs A, Jones-McLean E, Le-Petit C. Technical report for the National Committee on Colorectal Cancer Screening. 〈http://www.phac-aspc.gc.ca/ publicat/ncccs-cndcc/techrep-eng. php〉 (Accessed on November 10, 2010).
25. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
26. Newcomb PA, Storer BE, Morimoto LM, Templeton A, Potter JD. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 2003;95:622-5. (Pubitemid 36553509)
27. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
28. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicentre randomised controlled trial. Lancet 2010;375:1624-33.
29. Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: Randomised controlled trial. BMJ 2009;338:b1846.
30. Segnan N, Senore C, Andreoni B, et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy" - SCORE. J Natl Cancer Inst 2002;94:1763-72. (Pubitemid 36007754)
31. Weissfeld JL, Schoen RE, Pinsky PF, et al. Flexible sigmoidoscopy in the PLCO cancer screening trial: Results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 2005;97:989-97.
32. Ho C, Jacobs P, Sandha G, Noorani H, Skidmore B. Non-physicians performing screening flexible sigmoidoscopy: Clinical efficacy and cost-effectiveness (Technology report no 60). Assessment OCCOfHT, 2006. 〈http://www.cadth.ca/media/pdf/277- endoscopist-model-tr-e.pdf〉 (Accessed on October 8, 2010).
33. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:1-8.
34. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7. (Pubitemid 32162983)
35. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995;155:1741-8.
36. Singh H, Turner D, Xue L, Targownik LE, Bernstein CN. Risk of developing colorectal cancer following a negative colonoscopy examination: Evidence for a 10-year interval between colonoscopies. JAMA 2006;295:2366-73. (Pubitemid 43788104)
37. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population-based surveillance by colonoscopy: Effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999;34:414-20. (Pubitemid 29232378)
38. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81. (Pubitemid 24015040)
39. Canadian Partnership Against Cancer. Flexible sigmoidoscopy watching brief 2nd iteration of expert panel report, 2010. 〈http://www. partnershipagainstcancer.ca/sites/default/files/FS- Watching-Brief-2nd- Iteration-Final-ENG.pdf〉 (Accessed on October 8, 2010).
40. Stevenson G. Colon imaging in radiology departments in 2008: Goodbye to the routine double contrast barium enema. Can Assoc Radiol J 2008;59:174-82.
41. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U. Protection from right- and left-sided colorectal neoplasms after colonoscopy: Population-based study. J Natl Cancer Inst 2010;102:89-95.
42. Lakoff J, Paszat LF, Saskin R, Rabeneck L. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: A population-based study. Clin Gastroenterol Hepatol 2008;6:1117-21.
43. Singh H, Nugent Z, Mahmud SM, Demers AA, Bernstein CN. Predictors of colorectal cancer after negative colonoscopy: A population-based study. Am J Gastroenterol 2010;105:663-73.
44. Rex DK. Preventing colorectal cancer and cancer mortality with colonoscopy: What we know and what we don't know. Endoscopy 2010;42:320-3.
45. Johnson CD, MacCarty RL, Welch TJ, et al. Comparison of the relative sensitivity of CT colonography and double-contrast barium enema for screen detection of colorectal polyps. Clin Gastroenterol Hepatol 2004;2:314-21. (Pubitemid 38447196)
46. Ramos C, De Jesus-Caraballo J, Toro DH, et al. Is barium enema an adequate diagnostic test for the evaluation of patients with positive fecal occult blood? Bol Asoc Med P R 2009;101:23-8.
47. Sosna J, Sella T, Sy O, et al. Critical analysis of the performance of double-contrast barium enema for detecting colorectal polyps > or = 6 mm in the era of CT colonography. AJR Am J Roentgenol 2008;190:374-85. (Pubitemid 351196608)
48. Rockey DC, Koch J, Yee J, McQuaid KR, Halvorsen RA. Prospective comparison of air-contrast barium enema and colonoscopy in patients with fecal occult blood: A pilot study. Gastrointest Endosc 2004;60:953-8. (Pubitemid 39655470)
49. Rockey DC, Paulson E, Niedzwiecki D, et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: Prospective comparison. Lancet 2005;365:305-11. (Pubitemid 40139107)
50. Rosman AS, Korsten MA. Meta-analysis comparing CT colonography, air contrast barium enema, and colonoscopy. Am J Med 2007;120:203-10,e4.
51. Bosworth HB, Rockey DC, Paulson EK, et al. Prospective comparison of patient experience with colon imaging tests. Am J Med 2006;119:791-9. (Pubitemid 44291630)
52. Neri E, Faggioni L, Cerri F, et al. CT colonography versus double-contrast barium enema for screening of colorectal cancer: Comparison of radiation burden. Abdom Imaging 2009;35:596-601.
53. Zalis ME, Barish MA, Choi JR, et al. CT colonography reporting and data system: A consensus proposal. Radiology 2005;236:3-9. (Pubitemid 40853289)
54. Halligan S, Altman DG, Taylor SA, et al. CT colonography in the detection of colorectal polyps and cancer: Systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology 2005;237:893-904. (Pubitemid 41636379)
55. Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: Computed tomographic colonography. Ann Intern Med 2005;142:635-50. (Pubitemid 40529961)
56. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006;130:1872-85. (Pubitemid 43668826)
57. Rex DK, Overhiser AJ, Chen SC, Cummings OW, Ulbright TM. Estimation of impact of American College of Radiology recommendations on CT colonography reporting for resection of high-risk adenoma findings. Am J Gastroenterol 2009;104:149-53
58. Telford JJ, Levy AR, Sambrook JC, Zou D, Enns RA. The cost-effectiveness of screening for colorectal cancer. CMAJ 2007;182:1307-13.
59. Brenner DJ, Georgsson MA. Mass screening with CT colonography: Should the radiation exposure be of concern? Gastroenterology 2005;129:328-37. (Pubitemid 41002065)
60. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol 2009;104:739-50.
61. Ahlquist DA, Sargent DJ, Loprinzi CL, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008;149:441-50,W81.
62. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14. (Pubitemid 39665324)
63. Rabeneck L, Paszat LF, Hilsden RJ, et al. Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology 2008;135:1899-906,906 e1.
64. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004;329:133.
65. Allard J, Cosby R, Del Giudice ME, Irvine EJ, Morgan D, Tinmouth J. Gastroscopy following a positive fecal occult blood test. and negative colonoscopy: Systematic review and guideline. Can J Gastroenterol 2010;24:113-20.
66. Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001;48:812-5. (Pubitemid 32476984)
67. Imperiale T, Glowinski E, Lin-Cooper C, Larkin G, Rogge J, Ransohoff D. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med 2008;359:1218-24.
68. Lieberman DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007;133:1077-85. (Pubitemid 47494453)
69. Rabeneck L, Paszat LF, Saskin R. Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy. Clin Gastroenterol Hepatol 2010;8:275-9.
70. Singh H, Penfold RB, De Coster C, Au W, Bernstein CN, Moffatt M. Predictors of serious complications associated with lower gastrointestinal endoscopy in a major city-wide health region. Can J Gastroenterol 2010;24:425-30.
71. Chen SC, Rex DK. Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol 2007;102:856-61. (Pubitemid 46496608)
72. Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Gastrointest Endosc 2006;63:S16-28.